MARSHALL WACE, LLP - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 120 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,361,908
-72.4%
158,411
-79.7%
0.01%
-70.6%
Q2 2023$8,559,998
+303.7%
781,735
+221.5%
0.02%
+240.0%
Q1 2023$2,120,538
+313.6%
243,181
+197.4%
0.01%
+400.0%
Q4 2022$512,760
+1453.8%
81,780
+643.5%
0.00%
Q2 2022$33,000
-98.0%
11,000
-91.4%
0.00%
-100.0%
Q1 2019$1,688,000
+294.4%
127,178
+134.0%
0.01%
+100.0%
Q4 2018$428,00054,3580.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders